WeissLaw LLP: Apyx Medical Corporation is the Subject of a Legal Investigation

Stock Information for Qumu Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Qumu Corporation

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.